Business Wire

O-RAN ALLIANCE Announces Cooperation with ATIS, Activities at MWC Barcelona 2023, 7th Release of Open Software and New OTICs

Share

New MoU between O-RAN ALLIANCE and ATIS opens the opportunity for ATIS adopting O-RAN specifications

O-RAN ALLIANCE and ATIS signed a Memorandum of Understanding to further both organizations’ mutual objectives to advance the industry towards more intelligent, open, virtualized and global standards-compliant Radio Access Networks (RAN).

“O-RAN is welcoming the opportunity to work with ATIS,” said Alex Jinsung Choi, Chairman of the O-RAN ALLIANCE and SVP Group Technology at Deutsche Telekom. “We look forward to the opportunity to consider ATIS adopting O-RAN specifications for ATIS Open RAN standards and working together to define the next generation of open and intelligent RAN technology.”

O-RAN ALLIANCE event and demos at MWC Barcelona to bring latest updates from the open RAN ecosystem

O-RAN ALLIANCE plans to hold its next industry event on February 28, 2023 from 15:30-16:30 CET at MWC Barcelona 2023, hosted by Deutsche Telekom at Hall 3 Stand 3M31. The event will include:

  • Keynotes by Alex Jinsung Choi, Chairman of the O-RAN ALLIANCE and Stefan Engel-Flechsig, O-RAN ALLIANCE’s COO
  • Views on open RAN testing & integration and security by CSPs from Asia, Europe and Americas
  • Industry panel discussions on regional development (deployments and trials), security, ecosystem maturity and energy efficiency by key CSPs and vendors from the O-RAN ecosystem

Follow our website for speaker lineup and further updates.

More than 60 O-RAN member companies plan to present demonstrations of their O-RAN based technology and solutions at MWC Barcelona or the O-RAN Virtual Exhibition and welcome visitors to join their booths. O-RAN ALLIANCE plans to issue a map of the demos at the exhibition. Follow us on the O-RAN ALLIANCE LinkedIn channel to learn more, closer to the event.

O-RAN Software Community 7th release “G” expanded to 13 project streams

In December 2022, following on the half year release cycle, the O-RAN Software Community (OSC) published its 7th open software release named "G". For the G release, the OSC expanded to 13 project streams, adding a new AI/ML Framework project.

With each release, OSC’s open software continues to greatly help companies to develop, test and integrate their commercial open and intelligent RAN solutions. Contributions to OSC’s open software come from a diverse community, delivering a broad scope of software according to latest O-RAN ALLIANCE specifications.

"I am so delighted to see the 7th release and the addition of the new AI/ML Framework project stream from our open source community," said Chih-Lin I, Chief Scientist from China Mobile and Co-chair of O-RAN Technical Steering Committee. "With O-RAN ALLIANCE moving into its 5th year, we look forward to evolving towards a new phase. I deeply believe that the power of open source is essential in pushing O-RAN's progress to new heights in the coming years."

“The growth of the O-RAN Software Community has been tremendous. With the O-RAN SC G release, this milestone will help further accelerate O-RAN globally and advance the deployment of flexible networks demanding carrier-grade cloud-native infrastructure as we move towards an intelligent systems world fueled by innovative edge applications,” said Gil Hellmann, vice president, Telecom Solutions Engineering, Wind River. “For the latest O-RAN SC G release, Wind River has continued to provide key contributions to the INF project by working with the community to enable more Open RAN related features in StarlingX and implementing a framework supporting the latest published O2 interface, which is pivotal to cloud infrastructure management and deployment operations. We look forward to continuing our close collaboration.”

New Open Testing and Integration Centres (OTIC) approved in Japan and North America

O-RAN ALLIANCE is pleased to announce Japan OTIC and North American OTIC in NYC Metro Area/East (COSMOS) joining the community of Open Testing and Integration Centres. With this addition there are now 9 approved OTICs across Europe, the Americas and Asia.

“Shared testing and integration are key to delivering commercial O-RAN solutions, so it is great to see more OTICs being approved in North America and around the world,” said Igal Elbaz, Network CTO of AT&T and Board member of O-RAN ALLIANCE. “OTICs are also part of O-RAN PlugFests and the O-RAN Certification and Badging program, promoting more confidence in O-RAN products, components, and solutions within the industry.”

"We are delighted with the start of Japan OTIC, pinned by the opening ceremony last month, and believe the neutral and open testing environment for vendors will help to advance O-RAN solutions," said Naoki Tani, EVP and CTO at NTT DOCOMO and Board member of O-RAN ALLIANCE. "NTT DOCOMO has deployed 5G networks nationwide with O-RAN compliant equipment and intends to further expand the O-RAN ecosystem as co-host of Japan OTIC together with YRP R&D Promotion Committee and Japanese operators.”

For more about O-RAN ALLIANCE testing and integration efforts and the OTICs, please visit our website.

About O-RAN ALLIANCE

The O-RAN ALLIANCE is a world-wide community of more than 300 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.

For more information, please visit www.o-ran.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

O-RAN ALLIANCE PR Contact

Zbynek Dalecky
pr@o-ran.org
O-RAN ALLIANCE e.V.
Buschkauler Weg 27
53347 Alfter/Germany

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ThetaRay and Piie Collaborate in AI Technology for Insurance Payments8.2.2023 16:00:00 EET | Press release

ThetaRay, a leading provider of AI-powered transaction monitoring technology, and Piie, Inc., an insurtech providing an intelligent payment engine, today announced a collaboration to implement an advanced AML solution for insurance claim payments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230208005157/en/ Piie (Payments Intelligent Integration Engine) payments-as-a-service platform, including mobile application support. (Photo: Business Wire) Through the agreement, Piie (Payments Intelligent Integration Engine) will integrate ThetaRay’s AI-driven SONAR transaction monitoring AML solution to monitor and detect anomalies pointing to suspected financial crime on its payments-as-a-service platform that includes mobile application support. A scalable, secure payments platform headquartered in Charlotte, NC, Piie serves the insurance industry with an AI-driven real-time payments solution. Using ThetaRay’s transaction monitori

Novaliq Plans to File a Markting Authorisation Application for CyclASol® in the E.U. for the Treatment of Dry Eye Disease in July 20238.2.2023 16:00:00 EET | Press release

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced its plans for filing a Marketing Authorisation Application (MAA) for CyclASol® (ciclosporin ophthalmic solution), a first-of-its-kind anti-inflammatory product for the treatment of dry eye disease (DED) in the European Union. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) determined that CyclASol® is eligible to be reviewed in a centralized procedure to receive a Union Marketing Authorisation for the European Economic Area (EEA). In December 2022, EMA stated in its response that, based on the documentation provided by Novaliq, a submission is in the interest of patients at Community level under Article 3(2)b - Interest of patients of Regulation (EC) No 726/2004. Consequently, Novaliq has submitted a letter of intent to EMA to file the MAA in July 2023. Dry eye is one of the most

The IKEA Foundation Commits €10 Million to Provide Emergency Assistance in Türkiye and Northern Syria8.2.2023 15:50:00 EET | Press release

The donation will go to Médecins Sans Frontières’ (MSF) emergency fund to provide life saving care where medical needs are the greatest. This will support the delivery of essential aid, including medical assistance, psychological support and healthcare services to those most impacted by the devastating earthquake. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230208005519/en/ Image credit: Médecins Sans Frontières, Photographer: Omar Haj Kadour (Photo: Business Wire) The IKEA Foundation is also speaking with other partners who are operating in the region. These partners are coordinating with Turkish authorities to understand further needs and opportunities to provide additional assistance. This includes discussions with Better Shelter, looking at ways to provide modular temporary housing units in Türkiye and Syria. Per Heggenes, CEO of the IKEA Foundation, said: “We are deeply saddened by the devastation and loss of life

New Peer Reviewed Research Reinforces the Carbon Neutrality of Sustainably Sourced Biomass in the U.S. Southeast8.2.2023 15:00:00 EET | Press release

Enviva Inc. (NYSE: EVA), the world’s leading producer of sustainably sourced woody biomass, along with the U.S. Industrial Pellet Association (USIPA), welcome a recent study, titled “Impacts of the US southeast wood pellet industry on local forest carbon stocks.” The study has been peer-reviewed and published in a leading scientific journal, Nature, confirming that the wood pellet industry has met the overall condition of forest carbon neutrality in the U.S. Southeast between 2000 and 2019. According to the International Energy Agency (IEA), if harvest volumes (for wood products and energy) and losses related to mortality and disturbances do not exceed the growth across the whole forest, there is no net reduction in forest carbon stock. The 2022 study in Nature additionally confirms, by data, that carbon neutrality guidelines have been met by biomass producers in the U.S. Southeast, which is the world’s leading region for wood pellet production and export. Between 2000 and 2019, data a

Adrestia Therapeutics Partners with Leading Patient Advocacy Groups to Form Ataxia Telangiectasia Research Consortium8.2.2023 15:00:00 EET | Press release

Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, today announced it has co-founded a research consortium to find new treatments for ataxia telangiectasia (AT), a fatal, inherited, progressive neurodegenerative disorder that is typically diagnosed in young children. The consortium’s other founding members include the A-T Children’s Project, the AT Society and Action for AT. Adrestia is applying its synthetic rescue technology to systematically mine the human genome for novel targets which could be used as the basis for therapies for AT and related diseases. Currently, there are no corrective therapies for AT. “The entire Adrestia team is moved by the dedication of the AT community and we are honored to be working closely with our consortium partners to combine patient networks, scientific and other resources to accelerate the development of new treatment options, for which there is a desperate need,” said Robert Johnson, Chief Executive Officer of Adre

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom